Lexicon appoints Diane Sullivan to board; Frank Palantoni resigns after 18 years

LEXICON PHARMACEUTICALS, INC.

Diane Sullivan, former chief commercial officer at The Medicines Company, elected to Lexicon board effective July 27, 2023.
Sullivan will serve on audit committee; received initial stock option for 96,515 shares at $1.94 per share.
Non-employee director compensation includes $50k annual retainer plus committee fees (audit $10k, comp $7.5k, governance $5k).
Frank Palantoni resigned after 18 years, with his service culminating in INPEFA approval.
Sullivan's experience expected to support INPEFA launch and LX9211 program advancement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Diane E. Sullivan

Director

LXRX · LEXICON PHARMACEUTICALS, INC.

Effective: 2023-07-27
Filed: July 31, 2023, 7:59 PM ET

Effective July 27, 2023, our board of directors elected Diane E. Sullivan to serve as a member of our board of directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Diane E. Sullivan was elected as Director at LEXICON PHARMACEUTICALS, INC..

Action: elected
Role: Director

Exact text from the filing

Effective July 27, 2023, our board of directors elected Diane E. Sullivan to serve as a member of our board of directors.

View on SEC.gov

LEXICON PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001062822-23-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.